MHRA-102287-PIP01-25

Key Facts

Active Substance
Active Substance:
  • Clostridium botulinum, neurotoxin serotype A/B
Invented Name
Not yet available
PIP Number MHRA-102287-PIP01-25
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Powder for solution for injection
Therapeutic area
  • Neurology
  • Dermatology
Conditions / Indications
Conditions / Indications:
  • Treatment of skin wrinkling
Route(s) of administration
Route(s) of administration:
  • All routes of administration
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Clostridium botulinum, neurotoxin serotype A/B.pdf
Published Date 10/04/2026